The annual meeting of the American Heart Association was held this year from Nov. 6 to 9 in Chicago, with attendees including cardiovascular specialists, surgeons, and nurses as well as other health […]
The annual meeting of the American Heart Association was held this year from Nov. 6 to 9 in Chicago, with attendees including cardiovascular specialists, surgeons, and nurses as well as other health care professionals. The conference featured presentations focusing on the latest advances in cardiovascular medicine and surgery.
AHA: More Intensive BP Lowering Cuts Future Cardiovascular Risk After Stroke, TIA
FRIDAY, Nov. 13, 2026 (HealthDay News) — For adults with previous ischemic stroke or transient ischemic attack, targeting a systolic blood pressure <120 mmHg versus <140 mmHg yields a lower incidence of major cardiovascular events, according to a study published online Nov. 7 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Invasive Versus Conservative Management of Chronic Coronary Disease Has No Lasting Survival Benefit
FRIDAY, Nov. 13, 2026 (HealthDay News) — For patients with high-risk chronic coronary disease, long-term all-cause mortality does not differ with routine invasive versus initial conservative management, according to a study published online Nov. 7 in the Journal of the American Medical Association to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Discontinuing Statins Noninferior to Continuation in Older Adults Without Known CVD
FRIDAY, Nov. 13, 2026 (HealthDay News) — It is generally safe for older adults without a history of cardiovascular disease to discontinue statins for primary prevention, according to a study published online Nov. 7 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Pelacarsen Cuts Lipoprotein(a) Levels But Does Not Lower Risk for MACE
THURSDAY, Nov. 12, 2026 (HealthDay News) — For adults with preexisting cardiovascular disease, pelacarsen, an antisense oligonucleotide administered monthly lowers lipoprotein(a) levels, but does not reduce the occurrence of major adverse cardiovascular events, according to a study published online Nov. 7 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Cleaner Home Air Linked to Fewer Blood Sugar Spikes in Adults With Prediabetes
THURSDAY, Nov. 12, 2026 (HealthDay News) — Using portable filters to reduce exposure to air pollution may stabilize spikes in blood sugar for adults with prediabetes, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: IV Iron Replacement Tied to Improved Exercise Capacity in HFpEF With Iron Deficiency
THURSDAY, Nov. 12, 2026 (HealthDay News) — For patients with heart failure with preserved ejection fraction with iron deficiency, ferric derisomaltose improves measures of exercise capacity, according to a study published online Nov. 8 in Circulation to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Mothers” Chronic Hypertension Increases Risk for Critical Congenital Heart Disease in Offspring
FRIDAY, Nov. 6, 2026 (HealthDay News) — Chronic hypertension during pregnancy and prepregnancy diabetes are independently associated with an increased risk for critical congenital heart disease in offspring, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Valvular Heart Disease Deaths Rising Among Older Adults
FRIDAY, Nov. 6, 2026 (HealthDay News) — Valvular heart disease death rates increased from 2018 to 2023 and are predicted to remain higher than prepandemic levels through 2040, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Cannabis Use Linked to Increased Odds of Atherosclerotic CVD
THURSDAY, Nov. 5, 2026 (HealthDay News) — Cannabis use is associated with increased odds of atherosclerotic cardiovascular disease in specific subgroups, including never-smokers, women, and young adults without traditional risk factors, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Machine Learning Can Predict Hypertensive Crises 72 Hours Earlier
WEDNESDAY, Nov. 4, 2026 (HealthDay News) — A machine learning tool applied to continuous wearable blood pressure data can predict hypertensive crises up to 72 hours in advance, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Medically Tailored Meals Beneficial for Adults With T2DM, High BP
WEDNESDAY, Nov. 4, 2026 (HealthDay News) — For adults with type 2 diabetes and high blood pressure, an intervention of medically tailored meals is effective for improving diet quality, even with gradual down dosing of the intervention, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Caffeine-, Stimulant-Product Exposure Tied to Cardiovascular Event Reporting
WEDNESDAY, Nov. 4, 2026 (HealthDay News) — Caffeinated energy drinks and stimulant supplements are associated with disproportionate reporting of cardiovascular events, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
AHA: Rural Residence Is Strongest Predictor of Prehospital AMI Death
TUESDAY, Nov. 3, 2026 (HealthDay News) — Rural residence is the strongest independent predictor of prehospital death among acute myocardial infarction decedents, according to a study presented at the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
Paintball-Related Eye Injuries Declined 84.5 Percent From 2005 to 2025
Head-to-Head Comparisons Show Three Antidepressants Have Greater Long-Term Efficacy
Screening, Treating STIs During Pregnancy May Cut Preterm Birth Risk
Greater Estrogen Exposure Linked to Lower Cerebrovascular Pathology
AI Better Assesses Heart Function From MRI Than Clinicians
Oral Menopausal Hormone Therapy Linked to Venous Thromboembolic Risk
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy